Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Conditional ligands for Asian HLA variants facilitate the definition of CD8+ T-cell responses in acute and chronic viral diseases

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. High levels of neutralizing IL-6 autoantibodies in 0.1% of apparently healthy blood donors

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Knocking out IL-6 by vaccination

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Peripheral memory T cells specific for Arginase-1

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The targeting of tumor-associated macrophages by vaccination

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Neo-antigen specific memory T-cell responses in healthy individuals

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Survivin is overexpressed in several malignancies and in tumor-associated endothelium making it an attractive target for therapeutic cytotoxic T-cell responses. Thus, it would be important to test this notion in preclinical models. Consequently, we screened the murine survivin sequence for potential binding K(b)-restricted octamer peptide epitopes. Two epitopes, which bind strongly to K(b), were selected to test their immunogenicity in vivo. Spleen cells from mice vaccinated by intradermal injection of mature DC pulsed with these peptides displayed reactivity to the respective epitopes. The natural processing and presentation of these epitopes by tumor cells was evident by the killing of murine melanoma cells by vaccination-induced T cells. Subcutaneous challenge with syngeneic melanoma demonstrated the protective immunity of this vaccination. Notably, analysis of the vessel density in subcutaneous tumors revealed that survivin-specific vaccination significantly reduced the number of intratumoral vessels. In summary, we demonstrated the immunogenicity of two K(b)-restricted peptide epitopes derived from the murine survivin protein; moreover, survivin-specific vaccination not only resulted in a reduction of tumor cells but also the tumor supplying blood vessels. The presented preclinical model for survivin-directed vaccination may serve as a valuable tool to improve already running clinical trials in a syngeneic tumor model.

Original languageEnglish
JournalEuropean Journal of Immunology
Volume39
Issue number5
Pages (from-to)1419-24
Number of pages6
ISSN0014-2980
DOIs
Publication statusPublished - May 2009

    Research areas

  • Animals, Cancer Vaccines, Cell Line, Tumor, Enzyme-Linked Immunosorbent Assay, Epitopes, T-Lymphocyte, Female, H-2 Antigens, Humans, Immunohistochemistry, Immunotherapy, Inhibitor of Apoptosis Proteins, Melanoma, Mice, Mice, Inbred C57BL, Microtubule-Associated Proteins, Neovascularization, Pathologic, Repressor Proteins, T-Lymphocytes, Cytotoxic, Journal Article, Research Support, Non-U.S. Gov't

ID: 52222421